Table 1.

Patient characteristics

Characteristics*BSA group (n = 20)Equation group (n = 20)P
Sex
    Male11 (50%)11 (50%)
    Female9 (50%)9 (50%)
Age (y)57 (27-70)55 (27-69)0.60§
Height (m)1.74 (1.52-1.85)1.75 (1.54-1.87)0.83§
γ-Glutamyltransferase (units/L)76 (57)61 (46)0.34§
Smoking status0.63
    No16 (48%)17 (52%)
    Yes3 (60%)2 (40%)
Previous chemotherapy0.72
    0-114 (48%)15 (52%)
    ≥26 (55%)5 (45%)
Tumor type0.18
    Colorectal3 (43%)4 (57%)
    Gastric2 (40%)3 (60%)
    Pancreas2 (50%)2 (50%)
    Miscellaneous13 (54%)11 (46%)
UGT1A1*28 genotype**0.79
    6/69 (56%)7 (44%)
    6/78 (44%)10 (56%)
    7/71 (50%)1 (50%)
  • *Data are presented as absolute numbers with percentages in parentheses, unless stated otherwise.

  • P values result from χ2 test, unless stated otherwise.

  • Data presented as mean with range or SD in parentheses.

  • §P values resulting from two-sample t tests.

  • n = 38 (smoking status unknown in two patients).

  • Including sarcoma (4), esophageal carcinoma (3), breast cancer (3), (adeno)carcinoma of unknown primary (2), jejunal carcinoma (2), small cell lung cancer (2), urothelial carcinoma (2), melanoma (2), cholangiocarcinoma (1), ovarian carcinoma (1), medulloblastoma (1), and head and neck cancer (1).

  • **n = 36 (genotype unknown in four patients).